MedTrace Logo

Evaluate Dental Plaque Benefit of a Preventive Treatment Gel

NCT03546491 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2019-09-04

Study results available
· View outcomes & findings →

Summary

The objective of the study is to evaluate anti-plaque efficacy of a preventive treatment gel in a modified 4-day plaque model.

Conditions

  • Dental Plaque

Interventions

DRUG

Preventive Gel

0.4% Stannous Fluoride

DRUG

Marketed Control

0.243% Sodium Fluoride

Sponsors & Collaborators

  • Procter and Gamble

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-05-08
Primary Completion
2018-06-22
Completion
2018-06-22
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03546491 on ClinicalTrials.gov